Synthetic emmprin peptides inhibit tumor cell-fibroblast interaction-stimulated upregulation of MMP-2 and tumor cell invasion

International Journal of Oncology

Volumn 39, Issue 3, 2011, Pages 657-664

  Koga, Kaori ^a   Aoki, Mikiko ^b   Sameshima, Tetsuro ^c   Hamasaki, Makoto ^a   Egawa, Nagayasu ^d   Seiki, Motoharu ^e   Toole, Bryan P ^g   Suzumiya, Junji ^f   Nabeshima, Kazuki ^a,b  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b School of Medicine   (Japan)

^c Nippon Telegraph and Telephone Corporation Medical Center Tokyo   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f SHIMANE UNIVERSITY HOSPITAL   (Japan)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cell cell interaction; Emmprin; Fibroblast interaction; Glycosylation; Inhibitory peptide; MMPs; Peptide; Tumor invasion

Indexed keywords

CD147 ANTIGEN; GELATINASE A; SYNTHETIC PEPTIDE;

ARTICLE; CELL ACTIVITY; CELL INTERACTION; CELL INVASION; CELL TYPE; COCULTURE; CONTROLLED STUDY; FIBROBLAST; GLIOMA CELL; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; SARCOMA CELL; TUMOR CELL; UPREGULATION;

AMINO ACID SEQUENCE; ANTIGENS, CD147; CELL COMMUNICATION; CELL LINE, TUMOR; COCULTURE TECHNIQUES; FIBROBLASTS; GLIOBLASTOMA; HEK293 CELLS; HUMANS; MATRIX METALLOPROTEINASE 2; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASMS; PEPTIDE FRAGMENTS; UP-REGULATION;

EID: 79960011449     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1060     Document Type: Article

References (40)

1. Liotta LA and Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51: S5054-S5059, 1991.
2. Poulsom R, Pignatelli M, Stetler-Stevenson WG, et al: Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 141: 389-396, 1992.
3. Pyke C, Ralfkiaer E, Huhtala P, Hurskainen T, Dano K and Tryggvason K: Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res 52: 1336-1341, 1992.
4. Poulsom R, Hanby AM, Pignatelli M, et al: Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J Clin Pathol 46: 429-436, 1993. (Pubitemid 23167417)
5. Sameshima T, Nabeshima K, Toole BP, et al: Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett 157: 177-184, 2000. (Pubitemid 30629029)
6. Koga K, Nabeshima K, Aoki M, et al: Emmprin in epithelioid sarcoma: expression in tumor cell membrane and stimulation of MMP-2 production in tumor-associated fibroblasts. Int J Cancer 120: 761-768, 2007. (Pubitemid 46175394)
7. Nabeshima K, Suzumiya J, Nagano M, et al: Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas. J Pathol 202: 341-351, 2004. (Pubitemid 38325244)
8. Li R, Huang L, Guo H and Toole BP: Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts. J Cell Physiol 186: 371-379, 2001. (Pubitemid 32147720)
9. Sameshima T, Nabeshima K, Toole BP, et al: Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. Int J Cancer 88: 21-27, 2000.
10. Tang Y, Nakada MT, Kesavan P, et al: Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res 65: 3193-3199, 2005. (Pubitemid 40524601)
11. Baba M, Inoue M, Itoh K and Nishizawa Y: Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism. Biochem Biophys Res Commun 374: 111-116, 2008.
12. Su J, Chen X and Kanekura T: A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis. Cancer Lett 273: 140-147, 2009.
13. Yang JM, O'Neill P, Jin W, et al: Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim. J Biol Chem 281: 9719-9727, 2006. (Pubitemid 43864690)
14. Marieb EA, Zoltan-Jones A, Li R, et al: Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production. Cancer Res 64: 1229-1232, 2004. (Pubitemid 38235586)
15. Misra S, Ghatak S, Zoltan-Jones A and Toole BP: Regulation of multidrug resistance in cancer cells by hyaluronan. J Biol Chem 278: 25285-25288, 2003. (Pubitemid 36835275)
16. Kuang YH, Chen X, Su J, et al: Proteome analysis of multidrug resistance of human oral squamous carcinoma cells using CD147 silencing. J Proteome Res 7: 4784-4791, 2008.
17. Huet E, Vallee B, Szul D, et al: Extracellular matrix metalloproteinase inducer/CD147 promotes myofibroblast differentiation by inducing alpha-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling. FASEB J 22: 1144-1154, 2008. (Pubitemid 351519969)
18. Biswas C, Zhang Y, DeCastro R, et al: The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 55: 434-439, 1995.
19. Guo H, Zucker S, Gordon MK, Toole BP and Biswas C: Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem 272: 24-27, 1997. (Pubitemid 27021117)
20. Toole BP: Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function. Curr Top Dev Biol 54: 371-389, 2003.
21. Miyoshi I, Kubonishi I, Yoshimoto S and Shiraishi Y: A T-cell line derived from normal human cord leukocytes by co-culturing with human leukemic T-cells. Gann 72: 978-981, 1981. (Pubitemid 12172471)
22. Nishio J, Iwasaki H, Nabeshima K, et al: Establishment of a new human epithelioid sarcoma cell line, FU-EPS-1: molecular cytogenetic characterization by use of spectral karyotyping and comparative genomic hybridization. Int J Oncol 27: 361-369, 2005.
23. Ellis SM, Nabeshima K and Biswas C: Monoclonal antibody preparation and purification of a tumor cell collagenase-stimulatory factor. Cancer Res 49: 3385-3391, 1989. (Pubitemid 19162155)
24. Niiya D, Egawa N, Sakamoto T, et al: Identification and characterization of Lutheran blood group glycoprotein as a new substrate of membrane-type 1 matrix metalloproteinase 1 (MT1-MMP): a systemic whole cell analysis of MT1-MMP-associating proteins in A431 cells. J Biol Chem 284: 27360-27369, 2009.
25. Shulby SA, Dolloff NG, Stearns ME, Meucci O and Fatatis A: CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells. Cancer Res 64: 4693-4698, 2004. (Pubitemid 38924507)
26. Sun J and Hemler ME: Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res 61: 2276-2281, 2001. (Pubitemid 32692059)
27. Caudroy S, Polette M, Nawrocki-Raby B, et al: EMMPRIN-mediated MMP regulation in tumor and endothelial cells. Clin Exp Metastasis 19: 697-702, 2002. (Pubitemid 36092265)
28. Zucker S, Hymowitz M, Rollo EE, et al: Tumorigenic potential of extracellular matrix metalloproteinase inducer. Am J Pathol 158: 1921-1928, 2001.
29. Sato T, Ota T, Watanabe M, Imada K, Nomizu M and Ito A: Identification of an active site of EMMPRIN for the augmentation of matrix metalloproteinase-1 and -3 expression in a co-culture of human uterine cervical carcinoma cells and fibroblasts. Gynecol Oncol 114: 337-342, 2009.
30. Xu D and Hemler ME: Metabolic activation-related CD147-CD98 complex. Mol Cell Proteomics 4: 1061-1071, 2005.
31. Zhao P, Zhang W, Tang J, et al: Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147 Cancer Sci 101: 387-395, 2010.
32. Heller M, von der Ohe M, Kleene R, Mohajeri MH and Schachner M: The immunoglobulin-superfamily molecule basigin is a binding protein for oligomannosidic carbohydrates: an anti-idiotypic approach. J Neurochem 84: 557-565, 2003. (Pubitemid 36182254)
33. Horstkorte R, Schachner M, Magyar JP, Vorherr T and Schmitz B: The fourth immunoglobulin-like domain of NCAM contains a carbohydrate recognition domain for oligomannosidic glycans implicated in association with L1 and neurite outgrowth. J Cell Biol 121: 1409-1421, 1993.
34. Bordador LC, Li X, Toole B, et al: Expression of emmprin by oral squamous cell carcinoma. Int J Cancer 85: 347-352, 2000. (Pubitemid 30030407)
35. Jiang JL, Zhou Q, Yu MK, Ho LS, Chen ZN and Chan HC: The involvement of HAb18G/CD147 in regulation of store-operated calcium entry and metastasis of human hepatoma cells. J Biol Chem 276: 46870-46877, 2001.
36. Zou W, Yang H, Hou X, Zhang W, Chen B and Xin X: Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells. Cancer Lett 248: 211-218, 2007. (Pubitemid 46330554)
37. Chen X, Lin J, Kanekura T, et al: A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma. Cancer Res 66: 11323-11330, 2006. (Pubitemid 46009963)
38. Sato T, Sakai T, Noguchi Y, Takita M, Hirakawa S and Ito A: Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol Oncol 92: 47-56, 2004. (Pubitemid 38147370)
39. Rosenthal EL, Vidrine DM and Zhang W: Extracellular matrix metalloprotease inducer stimulates fibroblast-mediated tumor growth in vivo. Laryngoscope 116: 1086-1092, 2006. (Pubitemid 44334750)
40. Riethdorf S, Reimers N, Assmann V, et al: High incidence of EMMPRIN expression in human tumors. Int J Cancer 119: 1800-1810, 2006.